$NDRA ENDRA Life Sciences Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDRA Life Sciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENDRA Life Sciences Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ENDRA Life Sciences Inc. for free.
IRS Number: 260579295
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Trading Symbol: NDRA
Company Address: 3600 GREEN COURT SUITE 350 ANN ARBOR 48105
Phone number: 734-335-0468
Former name: Endra Inc., date of change: 2016-08-05
ENDRA Life Sciences Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | NDRA | ENDRA Life Science ... | Thornton Michael Milos | Chief Technology Of ... | Grant | A | 0.00 | 22,815 | 0 | 316,525 | 293.7 K to 316.5 K (+7.77 %) |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Tokman Alexander Y | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Harsh Michael | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | DIGIANDOMENICO ANTHONY | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Basenese Lou | Director | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Maloberti Renaud Bertrand | Chief Commercial Of ... | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Wells David R. | Chief Financial Off ... | Option Exercise | A | 2.64 | 25,000 | 66,000 | 25,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Thornton Michael Milos | Chief Technology Of ... | Option Exercise | A | 2.64 | 50,000 | 132,000 | 50,000 | |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Thornton Michael Milos | Chief Technology Of ... | Sell | S | 2.53 | 15,000 | 37,950 | 259,960 | 275 K to 260 K (-5.46 %) |
| Apr 07 2021 | NDRA | ENDRA Life Science ... | Thornton Michael Milos | Chief Technology Of ... | Sell | S | 2.37 | 18,750 | 44,438 | 274,960 | 293.7 K to 275 K (-6.38 %) |
| Jan 14 2021 | NDRA | ENDRA Life Science ... | Maloberti Renaud Bertrand | Chief Commercial Of ... | Sell | S | 1.10 | 13,696 | 15,066 | 1,580 | 15.3 K to 1.6 K (-89.66 %) |
| Jan 14 2021 | NDRA | ENDRA Life Science ... | Maloberti Renaud Bertrand | Chief Commercial Of ... | Sell | S | 1.05 | 6,304 | 6,619 | 15,276 | 21.6 K to 15.3 K (-29.21 %) |
| Jan 08 2021 | NDRA | ENDRA Life Science ... | Maloberti Renaud Bertrand | Chief Commercial Of ... | Sell | S | 0.94 | 8,731 | 8,207 | 21,580 | 30.3 K to 21.6 K (-28.80 %) |
| Jan 08 2021 | NDRA | ENDRA Life Science ... | Tokman Alexander Y | Director | Sell | S | 0.90 | 10,000 | 9,000 | 32,857 | 42.9 K to 32.9 K (-23.33 %) |
| Jan 06 2021 | NDRA | ENDRA Life Science ... | Maloberti Renaud Bertrand | Chief Commercial Of ... | Sell | S | 0.94 | 11,269 | 10,593 | 30,311 | 41.6 K to 30.3 K (-27.10 %) |